One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.
Steeply discounted overdose-reversal medicine now available to any Californian
California Gov. Gavin Newsom announced today that the state will sell Naloxone, the overdose-reversal medicine, to any resident at a steep discount. Here, a box of Narcan nasal spray sits at UC Berkeley student organization End Overdose’s table at Sproul Plaza on Jan. 23, 2024.
(
Juliana Yamada
/
CalMatters
)
Any Californian can purchase naloxone, an opioid overdose reversal medication, directly from the state at a discounted price, Gov. Gavin Newsom’s office announced Monday.
The medication is available online for $24 for a two-pack of the nasal spray, roughly half the market price of the drug. Previously, the discount was available only to government organizations and businesses.
“Life-saving medications shouldn’t come with a life-altering price tag. CalRx is about making essential drugs like naloxone affordable and accessible for all — not the privileged few,” Newsom said in a statement. CalRx is a Newsom initiative to bring down the cost of prescription drugs.
California has spent more than $1 billion fighting the opioid epidemic, which killed more than 8,900 people last year, according to preliminary data from the state health department. That represents a 13% increase in deaths from 2023.
-
The city of L.A. has scheduled a hearing to gather testimony from residents and consider revoking an oil company’s permit to operate a facility in Jefferson Park. -
Legislation advancing in Sacramento is the latest chapter in a tit for tat between conservative and liberal states since the overturning of Roe v. Wade. -
Federal health officials have identified a single supplier of the produce from Mexico that was served in Taco Bell restaurants in five states.
The Naloxone Distribution Project and Access Initiative is part of the strategy to stop overdoses, which began spiking in 2019 as fentanyl, a highly potent synthetic opioid, infused the market. The rate of fentanyl-related overdose deaths began declining last year, according to state data.
More than 6 million naloxone kits have been distributed to local governments and organizations since 2018, according to state data. About 355,000 overdoses have been reversed.
Sponsored message
In 2024, Newsom’s office announced a new supplier for the state initiative, Amneal Pharmaceuticals, which agreed to sell the steeply discounted drug to California. Days prior, Attorney General Rob Bonta announced a $273-million multistate settlement with the New Jersey-based company over its alleged failure to report suspicious opioid orders that contributed to the country’s epidemic.
“By getting this lower price, we are making the financial savings and able to use our dollars to buy more product, which of course is ultimately very much about saving lives,” said Elizabeth Landsberg, director of the Department of Health Care Access and Information, last year.
Naloxone is one of two current efforts by the state to make generic drugs more affordable under Newsom’s effort to lower the costs of pharmaceuticals. California has a $50-million contract to manufacture generic insulins for CalRx. That project is more than a year behind schedule.
Supported by the California Health Care Foundation (CHCF), which works to ensure that people have access to the care they need, when they need it, at a price they can afford. Visit www.chcf.org to learn more.
This article was originally published on CalMatters and was republished under the Creative Commons Attribution-NonCommercial-NoDerivatives license.
One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief
